Skip to main content
Español

Did you mean: trental rx 1

News: Gum Disease & Diabetes: A Strong Link

News & Articles (Drugs.com)

...move that public health experts say could... More news resources FDA Medwatch Drug Alerts Daily MedNews News for Health Professionals New Drug Approvals New Drug Applications Drug Shortages Clinical Trial Results Generic Drug Approvals Subscribe to our newsletter Whatever your topic of interest...

News: Denser Urban Neighborhoods Get People Walking

News & Articles (Drugs.com)

...study... Follow-Up Test For High Blood Pressure Condition Not Worthwhile, Researchers Say TUESDAY, May 6, 2025 — A test commonly used to confirm a condition linked to high blood pressure is often inaccurate, causing doctors to skip treatment that might improve... More news resources FDA Medwatch...

FDA Grants Accelerated Approval for Vanrafia (atrasentan) for Proteinuria Reduction in Primary IgA Nephropathy

New Drug Approvals (FDA)

...the ongoing Phase III ALIGN study evaluating whether Vanrafia slows disease progression as measured by estimated glomerular filtration rate (eGFR) decline at week 136 1 . The eGFR data are expected in 2026 and intended to support traditional FDA approval. “Today’s approval marks an...

FDA Approves Symbravo (meloxicam and rizatriptan) for the Acute Treatment of Migraine with or without Aura in Adults

New Drug Approvals (FDA)

...nervous system (CNS) disorders, today announced that the U.S. Food and Drug Administration (FDA) has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults. 1 Symbravo represents a novel multi-mechanistic approach to treating migraine that targets...

News: How To Handle Travel Stress

News & Articles (Drugs.com)

Medicine, news release Nov. 20, 2023 © 2025 HealthDay. All rights reserved. Posted January 2025 More news resources FDA Medwatch Drug Alerts Daily MedNews News for Health Professionals New Drug Approvals New Drug Applications Drug Shortages Clinical Trial Results Generic Drug Approvals Subscribe to...

See also:

Jaypirca

Jaypirca (pirtobrutinib) is a cancer medicine used to treat types of CLL, SLL, and MCL. Includes ...

Reviews & ratings
4 Reviews
View more

Deltasone

Deltasone is used for acute lymphocytic leukemia, adrenocortical insufficiency, allergic reactions ...

Reviews & ratings
6.6 / 10
8 Reviews
View more
Featured

Ozempic

Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...

Reviews & ratings
6.6 / 10
1,518 Reviews
View more

Rituxan

Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...

Reviews & ratings
8.3 / 10
51 Reviews
View more

Kesimpta

Kesimpta (ofatumumab) is used to treat relapsing forms of multiple sclerosis. Includes Kesimpta ...

Reviews & ratings
6.9 / 10
75 Reviews
View more

Jakafi

Jakafi (ruxolitinib) is used to treat myelofibrosis, polycythemia vera, and graft versus host ...

Reviews & ratings
7.5 / 10
33 Reviews
View more

Calquence

Calquence (acalabrutinib) is used to treat chronic lymphocytic leukemia (CLL), and mantle cell ...

Reviews & ratings
8.8 / 10
34 Reviews
View more

Brukinsa

Brukinsa is used to treat adults with mantle cell lymphoma, Waldenström’s macroglobulinemia, ma ...

Reviews & ratings
8.5 / 10
34 Reviews
View more

Venclexta

Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...

Reviews & ratings
8.6 / 10
11 Reviews
View more

Cytoxan

Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...

Reviews & ratings
7 Reviews
View more

FDA Approves Leqembi (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

New Drug Approvals (FDA)

Accelerated Approval Pathway - May 9, 2022 Eisai Initiates Rolling Submission to the U.S. FDA for Biologics License Application of Lecanemab (BAN2401) for Early Alzheimer's Disease Under the Accelerated Approval Pathway - September 27, 2021 Leqembi (lecanemab-irmb) FDA Approval History More news resources FDA...

FDA Alert: FDA Safety Communication: Labeling Changes on Mortality, Kidney Injury, and Excess Bleeding with Hydroxyethyl Starch Products

Drug Alerts (FDA)

...increases blood loss during major surgery: results from a randomized controlled trial. Ann Surg 2014; 259 (2):249-54. Source: FDA More news resources FDA Medwatch Drug Alerts Daily MedNews News for Health Professionals New Drug Approvals New Drug Applications Drug Shortages Clinical Trial Results Generic...

News: Ozempic Could Help Curb Alcoholism

News & Articles (Drugs.com)

...resources FDA Medwatch Drug Alerts Daily MedNews News for Health Professionals New Drug Approvals New Drug Applications Drug Shortages Clinical Trial Results Generic Drug Approvals Subscribe to our newsletter Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your...

Clinical Trials: Actuate Announces FDA Rare Pediatric Disease Designation Granted to Elraglusib for Treatment of Ewing Sarcoma MedNews

Clinical Trial Results (FDA)

...sarcomas. To date, the study has enrolled 8 patients with relapsed / refractory EWS (>1 remission) treated with the combination of elraglusib and topotecan / cyclophosphamide. Rare Pediatric Disease Designation is granted by the FDA for serious or life-threatening diseases that affect fewer than 200,000...

Clinical Trials: Alkeus Pharmaceuticals Receives FDA Rare Pediatric Disease and Fast Track Designations for Gildeuretinol as a Treatment for Stargardt Disease MedNews

Clinical Trial Results (FDA)

...treatment of Stargardt disease and for geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Source: Alkeus Pharmaceuticals, Inc. Posted: November 2024 More news resources FDA Medwatch Drug Alerts Daily MedNews News for Health Professionals New Drug Approvals New Drug Applications...